Suggestions
Alex Springer
Strategy & Operations, Alpenglow Biosciences
Alex Springer is a dynamic leader with extensive global work experience spanning ten countries and three continents, renowned for expertise in international joint ventures, strategic initiative launch and scaling, and new revenue stream development.
Specializing in diverse work environments from startups to multinational Fortune 100 companies, Alex excels in leading entrepreneurial projects from strategy definition to large-scale implementation.
With a solid technical and analytical background, Alex brings excellent quantitative rigor and data-driven decision-making skills to the table, fostering cross-functional support through relationship building and clear communication in complex and evolving landscapes.
Currently serving as the Chief of Staff at Alpenglow Biosciences, a venture-backed life sciences company revolutionizing pathology through AI-powered 3D insights to expedite drug development.
His specialties include project management, strategic planning, new business development, post-merger integration, partner and alliance management, operational change, proof of concept creation, executive communication, experimental design, implementation and scaling, and global business strategies.
Education-wise, Alex holds a Bachelor of Science (B.Sc.) in Mechanical Engineering with a Minor in Management from Massachusetts Institute of Technology, a Master's of Management in Global Affairs with a concentration in International Studies from Tsinghua University, and a Master's degree in the Management of Global Affairs from Schwarzman Scholars.
His professional journey includes roles such as Vice President Strategy Operations and Chief of Staff at Alpenglow Biosciences, Partner Strategy Manager and Analyst at Zillow, Project Leader for Joint Venture Integration, and Global Strategy Associate at Delta Air Lines, among other notable positions.
Highlights
Alpenglow is hiring! Come join as our newest Chief of Staff!
Looking forward to attending the J.P. Morgan Healthcare Conference in San Francisco next week. Alpenglow Biosciences has some incredible announcements in store for 2023 as we continue to accelerate drug development with AI-enabled #3DSpatialBiology. We're lining up exciting collaborations to bring our platform to discovery, translational, and clinical research. Please reach out if you would like to meet and learn more! #jpm2023 #jpm23 #healthcare
